Product Liability

  • November 2, 2006

    Ortho-McNeil Faces More Suits Over Contraceptive

    Ortho-McNeil Pharmaceutical Co., the manufacturer of the popular birth-control patch Ortho Evra, found itself in court again on Wednesday as additional lawsuits were filed by women who claim the contraceptive caused serious illnesses and at least one death.

  • November 1, 2006

    Glaxo Agrees To Settle Paxil Litigation For $63.8M

    GlaxoSmithKline PLC is dishing out $63.8 million to settle claims in a class action lawsuit that it marketed its antidepressant drug Paxil to kids and teenagers while hiding information about the drug’s safety.

  • October 31, 2006

    First Personal Injury Suit Brought Over Plavix

    On the same day that generic maker Apotex begged the Federal Circuit Court of Appeals to allow it to make a copycat version of the drug Plavix, two plaintiffs firms Tuesday served Plavix makers Bristol-Myers Squibb and Sanofi-Aventis with the first personal injury lawsuit over the drug.

  • October 24, 2006

    Knee Implant Suit Alleges Fraud, Medical Battery

    A woman who claims she suffered because of defective knee implants has targeted Encore Medical Corp. in a 10-count complaint alleging the company committed fraud when it said its prosthetic knee devices were safe and accusing the doctor that implanted the device of medical battery.

  • October 20, 2006

    Merck Still Vows To Fight Vioxx Cases One Suit At A Time

    Even with nearly 24,000 Vioxx-related lawsuits filed around the country, Merck & Co. is still reportedly looking to thwart any consolidation of cases.

  • October 17, 2006

    Class Action To Proceed Against St. Jude Medical

    A federal judge has granted class action status to a lawsuit brought by more than 11,000 people who received one of St. Jude Medical Inc.’s allegedly defective Silzone heart valves.

  • October 16, 2006

    Bayer Hires Counsel To Look At Trasylol Disclosure

    Bayer AG has appointed independent counsel to review the company’s failure to disclose to the U.S. Food and Drug Administration a study that revealed health risks posed by its heart surgery drug, Trasylol.

  • October 13, 2006

    FDA Clears Silicone Breast Implant Maker Of Wrongdoing

    The U.S. Food and Drug Administration cleared a silicone breast implant manufacturer of committing any wrongdoing after reviewing allegations by a former employee that the company withheld data on the safety of the implants, the FDA said Thursday.

  • October 16, 2006

    Eli Lilly Hit With Another Suit Over Zyprexa

    Eli Lilly & Co. has been hit with another lawsuit over it schizophrenia drug, Zyprexa, adding to the pharmaceutical company’s legal woes over one of its top-selling drugs.

  • October 11, 2006

    Wyeth’s Motion For Mistrial Granted In Prempro Case

    In a surprise turnaround, a Pennsylvania state court judge has declared a mistrial in the first state court trial over Wyeth’s hormone replacement therapy drug, overturning a jury’s finding that Prempro was a cause of a woman's breast cancer.

  • October 10, 2006

    Congress Should Make FDA Effective: Report

    Congress should better regulate and should give more money to the U.S. Food and Drug Administration so it can make drugs safer for consumers, according to a report published Monday.

  • October 6, 2006

    Appeals Court Reinstates Case Over Diabetes Drug

    A federal appeals court reinstated a case Thursday brought by several Michigan residents who say they were hurt from taking the diabetes drug, Rezulin, which was yanked from the market in 2000.

  • October 4, 2006

    Wyeth Found Liable In Hormone Replacement Trial

    After six days of deliberations, jurors in the first state court trial over Wyeth’s hormone replacement therapy drugs finally reached a decision on Wednesday, finding that Prempro was a cause of a woman's breast cancer and ordering the drug maker to shell out $1 million in compensatory damages.

  • September 29, 2006

    Report: FDA Should Improve Defibrillator Communication

    An association of doctors who implant defibrillators and pacemakers has recommended that the U.S. Food and Drug Administration enhance existing post-market surveillance databases and better communicate with the public about device malfunctions.

  • September 28, 2006

    Jury Deadlocks In Wyeth Hormone Replacement Trial

    Jurors in the first state court trial over claims that Wyeth’s hormone replacement therapy drugs increase the risk of heart disease, stroke and cancer remained deadlocked on Thursday, with the judge ordering them back to court on Friday to attempt to reach a verdict.

  • September 27, 2006

    Merck Scores Second Win In Vioxx Onslaught

    Merck & Co. said late Tuesday that a jury had cleared the company of responsibility for a Kentucky man's heart attack, marking the company’s second federal win in the slew of litigation it faces over its painkiller Vioxx.

  • September 26, 2006

    EU Regulator To Re-Examine Safety Of Common Drugs

    Europe’s top drug agency has launched another review of commonly used anti-inflammatory drugs amid concerns over a link to heightened risk of heart attacks.

  • September 26, 2006

    As Vioxx Deadline Looms, Merck Faces More Suits

    Pharmaceutical giant Merck & Co. may be plunged into even deeper hot water in the next few days over its painkiller Vioxx, as plaintiffs attorneys rush to file additional lawsuits ahead of a September 30 deadline.

  • September 25, 2006

    FDA Plans Studies Of On-The-Market Medications

    The Food & Drug Administration has ordered a first round of studies to address the safety of medicines already on the market. Attention deficit hyperactivity disorder, osteoporosis and contraceptive medications will be the first to face scrutiny.

  • September 20, 2006

    AMS Health Sciences Settles Ephedra Suit

    Natural foods company AMS Health Sciences Inc. settled a contentious wrongful-death claim Wednesday stemming from its past sales of ephedra-based products. The lawsuit was the last in a series of claims against AMS over the now-banned herbal product.